Additional information
HCl-1797986-78-7
Pale yellow Powder
842138-74-3
ACI-020804
193.0-194.2°C
C9H7BrN4S
283.15
Ambient
2-8°C
ocular hypertension
Pharmaceutical Impurity Standards
N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
1-(5-Bromoquinoxalin-6-yl)thiourea
Brimonidine Related Compound B; N-(5-Bromo-6-quinoxalinyl)thiourea; (5-Bromo-6-quinoxalinyl)thiourea





![TOFACITINIB DIMER (25 mg) (1,3-Bis{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-1,3-propanedione)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)